CLINICAL_TRIALS
trial_result
· 2010-12-13
Clinical Trial Update: ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®) [Phase 3]
Summary
This update reports the results of a long-term Phase 3 study of VIVITROL (naltrexone extended-release) for alcoholism, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alkermes, Inc. | Conditions: Alcoholism | Phase 3 | Status: COMPLETED | Results posted: 2010-12-13